Abiopharma

New Form SCHEDULE 13D/A - TRINITY BIOTECH PLC Filed: 2025-12-15 AccNo: 0001193125-25-319692 Size: 275 KB

Director Gray Robert 🟢 acquired 135.9K shares (1 derivative) of enVVeno Medical Corp (NVNO) at $0.33 Transaction Date: Dec 11, 2025 | Filing ID: 027834

Director Jenusaitis Matthew 🟢 acquired 135.9K shares (1 derivative) of enVVeno Medical Corp (NVNO) at $0.33 Transaction Date: Dec 11, 2025 | Filing ID: 027832

📋 Erasca Foundation (Foundation) plans to sell 8K shares of Erasc, Inc. (at $3.65 each, total $30K) Filed: Dec 15, 2025 | ID: 057210

Director Shrivastava Sanjay 🟢 acquired 135.9K shares (1 derivative) of enVVeno Medical Corp (NVNO) at $0.33 Transaction Date: Dec 11, 2025 | Filing ID: 027826

ENRIGHT PATRICK G 🟢 acquired 5.9K shares of Vera Therapeutics, Inc. (VERA) at $42.50 Transaction Date: Dec 11, 2025 | Filing ID: 319649

Director Mehta Vimal 🟡 adjusted position in 0 shares (2 derivative) of BioXcel Therapeutics, Inc. (BTAI) Transaction Date: Dec 14, 2025 | Filing ID: 121304

Steinhart Richard I 🟡 adjusted position in 0 shares (2 derivative) of BioXcel Therapeutics, Inc. (BTAI) Transaction Date: Dec 14, 2025 | Filing ID: 121303

Rodriguez Javier 🟡 adjusted position in 0 shares (2 derivative) of BioXcel Therapeutics, Inc. (BTAI) Transaction Date: Dec 14, 2025 | Filing ID: 121302

Yocca Frank 🟡 adjusted position in 0 shares (2 derivative) of BioXcel Therapeutics, Inc. (BTAI) Transaction Date: Dec 14, 2025 | Filing ID: 121300